BACKGROUND: Chromosome 13q deletion is associated with varying phenotypes, which seem to depend on the location of the deleted segment. Although various attempts have been made to link the 13q deletion intervals to distinct phenotypes, there is still no acknowledged consensus correlation between the monosomy of distinct 13q regions and specific clinical features. METHODS: 14 Italian patients carrying partial de novo 13q deletions were studied. Molecular-cytogenetic characterisation was carried out by means of array-comparative genomic hybridisation (array-CGH) or fluorescent in situ hybridisation (FISH). RESULTS: Our 14 patients showed mental retardation ranging from profound-severe to moderate-mild: eight had central nervous system (CNS) anomalies, including neural tube defects (NTDs), six had eye abnormalities, nine had facial dysmorphisms and 10 had hand or feet anomalies. The size of the deleted regions varied from 4.2 to 75.7 Mb. CONCLUSION: This study is the first systematic molecular characterisation of de novo 13q deletions, and offers a karyotype-phenotype correlation based on detailed clinical studies and molecular determinations of the deleted regions. Analyses confirm that patients lacking the 13q32 band are the most seriously affected, and critical intervals have been preliminarily assigned for CNS malformations. Dose-sensitive genes proximal to q33.2 may be involved in NTDs. The minimal deletion interval associated with the Dandy-Walker malformation (DWM) was narrowed to the 13q32.2-33.2 region, in which the ZIC2 and ZIC5 genes proposed as underlying various CNS malformations are mapped.
BACKGROUND: Chromosome 13q deletion is associated with varying phenotypes, which seem to depend on the location of the deleted segment. Although various attempts have been made to link the 13q deletion intervals to distinct phenotypes, there is still no acknowledged consensus correlation between the monosomy of distinct 13q regions and specific clinical features. METHODS: 14 Italian patients carrying partial de novo 13q deletions were studied. Molecular-cytogenetic characterisation was carried out by means of array-comparative genomic hybridisation (array-CGH) or fluorescent in situ hybridisation (FISH). RESULTS: Our 14 patients showed mental retardation ranging from profound-severe to moderate-mild: eight had central nervous system (CNS) anomalies, including neural tube defects (NTDs), six had eye abnormalities, nine had facial dysmorphisms and 10 had hand or feet anomalies. The size of the deleted regions varied from 4.2 to 75.7 Mb. CONCLUSION: This study is the first systematic molecular characterisation of de novo 13q deletions, and offers a karyotype-phenotype correlation based on detailed clinical studies and molecular determinations of the deleted regions. Analyses confirm that patients lacking the 13q32 band are the most seriously affected, and critical intervals have been preliminarily assigned for CNS malformations. Dose-sensitive genes proximal to q33.2 may be involved in NTDs. The minimal deletion interval associated with the Dandy-Walker malformation (DWM) was narrowed to the 13q32.2-33.2 region, in which the ZIC2 and ZIC5 genes proposed as underlying various CNS malformations are mapped.
Authors: David J Amor; Lucille Voullaire; Karen Bentley; Ravi Savarirayan; K H Andy Choo Journal: Am J Med Genet A Date: 2005-03-01 Impact factor: 2.802
Authors: L Y Brown; S Odent; V David; M Blayau; C Dubourg; C Apacik; M A Delgado; B D Hall; J F Reynolds; A Sommer; D Wieczorek; S A Brown; M Muenke Journal: Hum Mol Genet Date: 2001-04-01 Impact factor: 6.150
Authors: M C Bonaglia; R Giorda; E Mani; G Aceti; B-M Anderlid; A Baroncini; T Pramparo; O Zuffardi Journal: J Med Genet Date: 2005-11-11 Impact factor: 6.318
Authors: Victoria W Willard; Ibrahim Qaddoumi; Si Chen; Hui Zhang; Rachel Brennan; Carlos Rodriguez-Galindo; Matthew W Wilson; Sean Phipps Journal: J Clin Oncol Date: 2014-07-14 Impact factor: 44.544
Authors: Fernanda T Bellucco; Hélio Rodrigues de Oliveira-Júnior; Roberta Santos Guilherme; Silvia Bragagnolo; Ana B Alvarez Perez; Vera Ayres Meloni; Maria I Melaragno Journal: Mol Syndromol Date: 2019-03-06
Authors: F Rodjan; P de Graaf; A C Moll; S M Imhof; J I M L Verbeke; E Sanchez; J A Castelijns Journal: AJNR Am J Neuroradiol Date: 2010-04-22 Impact factor: 3.825
Authors: Benjamin D Solomon; Kenneth N Rosenbaum; Jeanne M Meck; Maximilian Muenke Journal: Am J Med Genet C Semin Med Genet Date: 2010-02-15 Impact factor: 3.908
Authors: Pim de Graaf; Sophia Göricke; Firazia Rodjan; Paolo Galluzzi; Philippe Maeder; Jonas A Castelijns; Hervé J Brisse Journal: Pediatr Radiol Date: 2011-08-18